Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record.

Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas

Open access
Gimotty, Phyllis A., Elder, David E., Fraker, Douglas L., Botbyl, Jeffrey, Sellers, Kimberly, Elenitsas, Rosalie, Ming, Michael E., Schuchter, Lynn, Spitz, Francis R., Czerniecki, Brian J., Guerry, DuPont·2007·Journal of Clinical Oncology

Abstract

Purpose: Most patients with melanoma have microscopically thin (≤ 1 mm) primary lesions and are cured with excision. However, some develop metastatic disease that is often fatal. We evaluated established prognostic factors to develop classification schemes with better discrimination than current American Joint Committee on Cancer (AJCC) staging. Patients and Methods: We studied patients with thin melanomas from the US population-based Surveillance, Epidemiology, and End Results (SEER) cancer registry (1988 to 2001; n = 26,291) and those seen by the University of Pennsylvania's Pigmented Lesion Group (PLG; 1972 to 2001; n = 2,389; Philadelphia, PA). AJCC prognostic factors were thickness, anatomic level, ulceration, site, sex, and age; PLG prognostic factors also included a set of biologically based candidate prognostic factors. Recursive partitioning was used to develop a SEER-based classification tree that was validated using PLG data. Next, a new PLG-based classification tree was developed using the expanded set of prognostic factors. Results: The SEER-based classification tree identified additional criteria to explain survival heterogeneity among patients with thin, nonulcerated lesions; 10-year survival rates ranged from 89.1% to 99%. The new PLG-based tree identified groups using level, tumor cell mitotic rate, and sex. With survival rates from 83.4% to 100%, it had better discrimination. Conclusion: Prognostication and related clinical decision making in the majority of patients with melanoma can be improved now using the validated, SEER-based classification. Tumor cell mitotic rate should be incorporated into the next iteration of AJCC staging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2006.08.1463

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 208

Metadata

Authors
Gimotty, P. A., Elder, D. E., Fraker, D. L., Botbyl, J., Sellers, K., Elenitsas, R., Ming, M. E., Schuchter, L., Spitz, F. R., Czerniecki, B. J., & Guerry, D.
Venue
Journal of Clinical Oncology
Published
2007-03-20
Volume
25
Issue
9
Pages
1129-1134
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2169042586
Cited by
208
References
0
FWCI
6.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas. https://app.cochat.ai/papers/10.1200/jco.2006.08.1463
The paper
Gimotty, P. A., Elder, D. E., Fraker, D. L., Botbyl, J., Sellers, K., Elenitsas, R., Ming, M. E., Schuchter, L., Spitz, F. R., Czerniecki, B. J., & Guerry, D. (2007). Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2006.08.1463

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.